Table: RaQualia Pharma -2018 group forecast
Oct 12 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2018 Dec 31, 2018
LATEST PREVIOUS
FORECAST FORECAST
Sales 1.03 1.39
Operating loss 1.02 loss 698 mln
Recurring loss 996 mln loss 680 mln
Net loss 1.02 loss 686 mln
EPS loss 50.31 yen loss 33.84 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T